×
Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study PDF
$ 40.00
Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study PDF quantity
$ 40.00
×
The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis PDF
$ 40.00
The Prevalence and Severity of Depressive Symptoms Along the Spectrum of Unipolar Depressive Disorders: A Post Hoc Analysis PDF quantity
$ 40.00
×
Maternal Postnatal Depression and Completion of Infant Immunizations: A UK Cohort Study of 196,329 Mother-Infant Pairs, 2006–2015 PDF
$ 40.00
Maternal Postnatal Depression and Completion of Infant Immunizations: A UK Cohort Study of 196,329 Mother-Infant Pairs, 2006–2015 PDF quantity
$ 40.00
×
Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression PDF
$ 40.00
Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression PDF quantity
$ 40.00
×
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) PDF
$ 40.00
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) PDF quantity
$ 40.00
×
The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines PDF
$ 40.00
The Role of Monoamine Oxidase Inhibitors in Depression Treatment Guidelines PDF quantity
$ 40.00
×
Longitudinal Follow-Up of Naturalistic Treatment Outcome in Patients With Trichotillomania PDF
$ 40.00
Longitudinal Follow-Up of Naturalistic Treatment Outcome in Patients With Trichotillomania PDF quantity
$ 40.00
×
Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data PDF
$ 40.00
Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data PDF quantity
$ 40.00
×
Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial PDF
$ 40.00
Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Psychopathology of Seasonal Affective Disorder Patients in Comparison With Major Depression Patients Who Have Attempted Suicide. PDF
$ 40.00
Psychopathology of Seasonal Affective Disorder Patients in Comparison With Major Depression Patients Who Have Attempted Suicide. PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
×
A Retrospective Review of Clinical Characteristics and Treatment Response in Body Dysmorphic Disorder Versus Obsessive-Compulsive Disorder PDF
$ 40.00
A Retrospective Review of Clinical Characteristics and Treatment Response in Body Dysmorphic Disorder Versus Obsessive-Compulsive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
